🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 842 of 857 · Phase 3 first, then by program name

  1. Standard of Care medication for early Alzheimer's Disease

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    small molecule active

    1 trial
  2. Standart medical treatment

    Tarsus Pharmaceuticals

    High Intensity Interval Training

    small molecule active

    1 trial
  3. Stapokibart

    The First People's Hospital of Lianyungang

    Primary Cutaneous Amyloidosis

    mab active

    1 trial
  4. Starch

    Hong Kong Baptist University

    Lens Opacity

    other completed

    1 trial
  5. Statin

    Hospital Authority, Hong Kong

    HCC

    small molecule terminated

    1 trial
  6. Step-up HP u FSH

    Universal Integrated

    Polycystic Ovary Syndrome

    small molecule completed

    1 trial
  7. Stereotactic body radiotherapy (SBRT)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HSCT

    other active

    1 trial
  8. Steroid and Proton Pump Inhibitor Therapy

    Takeda

    Suspected Eosinophilic Esophagitis

    small molecule completed

    1 trial
  9. Study Agent

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    small molecule active

    1 trial
  10. Study Product A (High-dose 2X)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hyperuricemia

    other active

    1 trial
  11. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight and Obesity

    other completed

    1 trial
  12. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight

    other completed

    1 trial
  13. Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval

    Biotech Pharmaceutical Co.,

    Diphtheria

    mab completed

    1 trial
  14. Suanzaoren Decoction and Huanglian Wendan Decoction

    The First People's Hospital of Lianyungang

    Traditional Chinese Medicine

    small molecule active

    1 trial
  15. Subconjunctival dexamethasone and general anesthesia

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cataract

    small molecule active

    1 trial
  16. Sucrose Iron,subcutaneous recombinant human erythropoietin,intravenous vitamin C

    The First People's Hospital of Lianyungang

    Anemia

    small molecule active

    1 trial
  17. Sufentanil

    The First People's Hospital of Lianyungang

    Anesthesia

    small molecule active

    1 trial
  18. Sulfadoxine-pyrimethamine

    United Therapeutics Europe Ltd

    Anaemia

    small molecule completed

    1 trial
  19. Sulfentanyl

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    small molecule active

    1 trial
  20. Super Cereal Plus (SC+)

    United Therapeutics Europe Ltd

    Moderate Acute Malnutrition (MAM)

    other terminated

    1 trial
  21. Supplementary Food

    United Therapeutics Europe Ltd

    Moderate Acute Malnutrition

    other completed

    1 trial
  22. Surgery combined with Target-reduction intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial
  23. Surgery-radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    other active

    1 trial
  24. Symbiotic Formula with DHA and antioxidants

    Quantum Biopharma

    Cystic Fibrosis

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources